SAN DIEGO, May 1, 2019 /PRNewswire/ -- Biocept, Inc.
(NASDAQ: BIOC), a molecular diagnostics company commercializing and
developing proprietary liquid biopsy tests that provide clinically
actionable information to physicians to improve the outcomes of
patients diagnosed with cancer, announces that it will release
financial results for the three months ended March 31, 2019 after the market closes on
Wednesday, May 8, 2019. The Company
will host a conference call for the investment community to discuss
the results and answer questions at 4:30
p.m. Eastern time (1:30 p.m. Pacific
time).
Individuals interested in participating on the conference call
may do so by dialing (855) 656-0927 for domestic callers, (855)
669-9657 for Canadian callers, or (412) 902-4109 for other
international callers. Those interested in listening to a webcast
of the live conference call may do so by
visiting https://www.webcaster4.com/Webcast/Page/1271/30137.
A replay of the conference call will be available for 48 hours
following the conclusion of the call by dialing (877) 344-7529 for
domestic callers, (855) 669-9658 for Canadian callers, or (412)
317-0088 for other international callers, and entering the replay
access code 10130332. A webcast replay will be available for 90
days at http://ir.biocept.com/events.cfm.
About Biocept
Biocept, Inc. is a molecular
diagnostics company with commercialized assays for lung, breast,
gastric, colorectal and prostate cancers, and melanoma. The Company
uses its proprietary liquid biopsy technology to provide physicians
with information for treating and monitoring patients diagnosed
with cancer. The Company's patented Target Selector™ liquid biopsy
technology platform captures and analyzes tumor-associated
molecular markers in both CTCs and in plasma (ctDNA). With
thousands of tests performed, the platform has demonstrated the
ability to identify cancer mutations and alterations to inform
physicians about a patient's disease and therapeutic options. For
additional information, please visit www.biocept.com.
Investor Contact:
LHA Investor
Relations
Jody Cain
Jcain@lhai.com
310-691-7100
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biocept-to-release-first-quarter-2019-financial-results-and-host-investor-conference-call-on-may-8-2019-300841546.html
SOURCE Biocept, Inc.